EyePoint Pharmaceuticals, Inc. — Form D

EyePoint Pharmaceuticals, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-12. The offering totals $35.0M, of which $9.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
James BarryDirectorAMERICAN CANYON, CA
Jay DukerDirectorWATERTOWN, MA
Douglas GodshallDirectorSanta Clara, CA
David MazzoDirectorGermantown, MD
Kristine PetersonDirectorAbingdon, Oxfordshire, X0
Michael RogersDirectorEDEN PRAIRIE, MN
Dario S PaggiarinoExecutive OfficerWATERTOWN, MA
Leonard S RossExecutive OfficerWATERTOWN, MA
Scott JonesExecutive OfficerAustin, TX
Nancy LurkerDirectorWATERTOWN, MA
Nancy LurkerExecutive OfficerWATERTOWN, MA
Dario Paggiarino, M.D.Executive OfficerWATERTOWN, MA
Goran AndoDirectorWATERTOWN, MA
George O ElstonExecutive OfficerWatertown, MA
Wendy O DiCiccoDirectorWatertown, MA
Ronald W EastmanDirectorWatertown, MA
Douglas W GodshallDirectorWatertown, MA
David R Guyer, M.D.DirectorWatertown, MA
John R Landis, Ph.D., M.S.DirectorWatertown, MA
Ye R LiuDirectorWatertown, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2021-01-06D$15.7M$15.7M
2018-04-12D$600K$450K

More